UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.

about

UbcH10 overexpression is less pronounced in older colorectal cancer patients.Large bowel cancer in the setting of inflammatory bowel disease UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability

P2860

Q51570862-1DA01B41-4CF4-4A49-9256-E6BC05C2FA0C Q57832665-F99B65E5-A72C-4A38-8A47-70024FAA2EF2 Q58803439-FEBEA4AE-1E08-478A-BA20-BA91488D327E

P2860

UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.

Item

http://www.wikidata.org/entity/Q38881708

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

UbcH10 expression can predict ...... or colorectal cancer patients.

@en

type

Item

label

UbcH10 expression can predict ...... or colorectal cancer patients.

@en

prefLabel

UbcH10 expression can predict ...... or colorectal cancer patients.

@en

P1476

UbcH10 expression can predict ...... or colorectal cancer patients.

@en

P2093

André Uchimura Bastos

http://www.w3.org/2001/XMLSchema#string

Antonella Federico

http://www.w3.org/2001/XMLSchema#string

Antonio Bianco

http://www.w3.org/2001/XMLSchema#string

Chiara Calabrese

http://www.w3.org/2001/XMLSchema#string

Chiara Carlomagno

http://www.w3.org/2001/XMLSchema#string

Cristina Quintavalle

http://www.w3.org/2001/XMLSchema#string

Francesco Milone

http://www.w3.org/2001/XMLSchema#string

Giancarlo Troncone

http://www.w3.org/2001/XMLSchema#string

Pierlorenzo Pallante

http://www.w3.org/2001/XMLSchema#string

Roberta Sgariglia

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex

Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase

UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.

A genetic model for colorectal tumorigenesis

The genomic landscapes of human breast and colorectal cancers

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

P304

793-807

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MC.22322

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nunzio Antonio Cacciola

P577

2015-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25917796

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.

about

P2860

P2860

UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921